Biota Holdings Ltd. - Financial and Strategic Analysis Review

Summary

Biota Holdings Ltd. - Financial and Strategic Analysis Review

Biota Holdings Limited (Biota) is an Australia-based drug discovery and clinical development company. The company is focused on discovery, development and commercialization of anti-infective products. The company has two licensed and marketed products namely: Relenza and OIA FLU Range. The company developed a series of candidate drugs for the treatment of respiratory syncytial virus (RSV) disease. It is headquartered at Notting Hill, Melbourne, Australia and employs 34 people.

Global Markets Direct, the leading business information provider, presents an in-depth business, strategic and financial analysis of Biota Holdings Ltd.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis and Global Markets Direct's views on the company.

Scope

• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• It provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial & strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitors' weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• Key Information
• Key Ratios
• Share Data
• Performance Chart
• List of Tables
• List of Figures
  • Key Facts
  • Business Description
  • Major Products and Services
  • Overview
  • History
  • SWOT Analysis Overview
  • Overview
  • Biota Holdings Ltd. - Strengths
  • Strong and Balanced Portfolio of Products:
  • Leading Anti-infective Drug Development Company:
  • Biota Holdings Ltd. - Weaknesses
  • Decrease in Royalty Payments:
  • Biota Holdings Ltd. - Opportunities
  • Partnerships and Associations:
  • Biota Holdings Ltd. - Threats
  • Regulatory Requirements
  • Competitive Pressures
  • Key Employees
  • Key Employee Biographies
  • Company Statement
  • Locations And Subsidiaries
  • Head Office
  • Financial Ratios
  • Capital Market Ratios
  • Annual Ratios
  • Interim Ratios
  • Ratio Charts
  • Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Biota Holdings Ltd., Key Facts
  • Biota Holdings Ltd., Key Ratios
  • Biota Holdings Ltd., Share Data
  • Biota Holdings Ltd., Key Facts
  • Major Products and Services
  • Biota Holdings Ltd., History
  • Biota Holdings Ltd., Key Employees
  • Biota Holdings Ltd., Key Employee Biographies
  • Biota Holdings Ltd., Ratios based on current share price
  • Biota Holdings Ltd., Annual Ratios
  • Biota Holdings Ltd., Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Biota Holdings Ltd., Performance Chart (2004 - 2008)
  • Biota Holdings Ltd., Ratio Charts